Global Next-Generation Sequencing (NGS) Services Market

1 INTRODUCTION OF GLOBAL NEXT-GENERATION SEQUENCING (NGS) SERVICES MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL NEXT-GENERATION SEQUENCING (NGS) SERVICES MARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL NEXT-GENERATION SEQUENCING (NGS) SERVICES MARKET, BY SERVICE TYPE
5.1 Overview
5.2 Targeted Resequencing& Custom Gene Panels
5.3 RNA-Seq
5.4 De Novo Sequencing
5.5 Exome Sequencing
5.6 Chip-Seq
5.7 Whole-Genome Sequencing
5.8 Methyl-Seq
5.9 Others

6 GLOBAL NEXT-GENERATION SEQUENCING (NGS) SERVICES MARKET, BY APPLICATION
6.1 Overview
6.2 Diagnostics
6.2.1 Oncology
6.2.2 Infectious Diseases
6.2.3 Rare Genetic Disorders
6.2.4 Reproductive Health
6.2.5 Other Diagnostic Applications
6.3 Drug Discovery
6.4 Biomarker Discovery
6.5 Agriculture & Animal Research
6.6 Others

7 GLOBAL NEXT-GENERATION SEQUENCING (NGS) SERVICES MARKET, BY TECHNOLOGY
7.1 Overview
7.2 Sequencing By Synthesis
7.3 Ion Semiconductor Sequencing
7.4 Single-Molecule Real-Time Sequencing
7.5 Nanopore Sequencing

8 GLOBAL NEXT-GENERATION SEQUENCING (NGS) SERVICES MARKET, BY END USER
8.1 Overview
8.2 Academic & Government Institutes and Research Centers
8.3 Hospitals & Clinics
8.4 Pharmaceutical & Biotechnology Companies
8.5 Others

9 GLOBAL NEXT-GENERATION SEQUENCING (NGS) SERVICES MARKET, BY GEOGRAPHY
9.1 Overview
9.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025

10 GLOBAL NEXT-GENERATION SEQUENCING (NGS) SERVICES MARKETCOMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies

11 COMPANY PROFILES
11.1 BGI
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments

11.2 Illumina Inc.
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments

11.3 Perkinelmer, Inc.
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments

11.4 Eurofins Scientific SE
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments

11.5 Gatc Biotech AG
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments

11.6 Macrogen, Inc.
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments

11.7 Qiagen N.V.
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments

11.8 Genotypic Technology Pvt. Ltd.
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments

11.9 Genewiz, Inc.
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Developments

11.10 DNA Link, Inc.
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Developments

11.11 Takara Bio Inc.
11.11.1 Overview
11.11.2 Financial Performance
11.11.3 Product Outlook
11.11.4 Key Developments

11.12 Scigenom Labs Pvt. Ltd
11.12.1 Overview
11.12.2 Financial Performance
11.12.3 Product Outlook
11.12.4 Key Developments

11.13 Novogene Corporation
11.13.1 Overview
11.13.2 Financial Performance
11.13.3 Product Outlook
11.13.4 Key Developments

11.14 Personalis, Inc.
11.14.1 Overview
11.14.2 Financial Performance
11.14.3 Product Outlook
11.14.4 Key Developments

11.15 LGC Limited
11.15.1 Overview
11.15.2 Financial Performance
11.15.3 Product Outlook
11.15.4 Key Developments

12 Appendix
12.1 Related Reports